
Brain Products GmbH
Brain Products GmbH
3 Projects, page 1 of 1
assignment_turned_in Project2015 - 2017Partners:Brain Products GmbH, UCL, Brain Products GmbHBrain Products GmbH,UCL,Brain Products GmbHFunder: UK Research and Innovation Project Code: EP/M001393/1Funder Contribution: 98,161 GBPTo increase our understanding of how the brain works and how it goes wrong in people with neurological conditions such as epilepsy we need to develop better systems for making measurements of brain activity. Electroencephalography (EEG) is an important modality in clinical and experimental neuroscience capable of measuring electrical changes occurring with sub-millisecond temporal resolution and a spatial resolution of centimetres while functional Magnetic Resonance Imaging (fMRI) can map haemodynamic changes over the entire the brain at a time-scale of seconds and spatial resolution of a few millimetres or better. Therefore together they can perform measurements across a greater range of brain activity occurring either at faster temporal or smaller spatial scales. However, during simultaneous EEG-fMRI acquisitions these both methods signal are degraded by noise related to motion, thereby significantly limiting the sensitivity of this type of study so far. The purpose of this application is to build a robust system that can perform these simultaneous EEG and fMRI measurements of brain activity. To achieve this goal we will integrate new fast fMRI pulse sequences because images obtained in shorter time intervals are intrinsically less motion sensitive (like a faster shutter speed on a camera). Also better modelling of motion will be possible if we obtain more images per unit time because we can better separate and model the different sources of signal and noise that occur in different frequency ranges. In addition, we will optimise motion detection and prospective motion correction (PMC) using a camera system that tracks the subject's motion and updates the image acquisition process so that patient motion is supressed. When using these improvements to fMRI data acquisition we will need to develop novel EEG artefact correction methods for simultaneous in-scanner EEG recording which currently rely on the repetitive nature of the artefact in time. Both motion and PMC are likely to make the artefact more variable and so will require the development of novel correction methods. Once we have developed this system we will apply it to ten patients with hard to treat epilepsy from Great Ormond Street Hospital who are being assessed for epilepsy surgery. This assessment aims to identify the epileptic brain regions and EEG-fMRI is a tool to help obtain this information. We will compare our current standard EEG-fMRI protocol which often suffers from degradation due to motion (particularly in young children) to our new robust EEG-fMRI incorporating PMC, fast fMRI and improved EEG artefact correction.
All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://beta.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=ukri________::9bc0e653f939e729868bd5bb2c82f228&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.eumore_vert All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://beta.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=ukri________::9bc0e653f939e729868bd5bb2c82f228&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.euassignment_turned_in Project2014 - 2022Partners:Hvidovre Hospital, General Electric (United Kingdom), Lightpoint Medical (United Kingdom), Brain Products GmbH, Moorfields Eye NHS Foundation Trust +136 partnersHvidovre Hospital,General Electric (United Kingdom),Lightpoint Medical (United Kingdom),Brain Products GmbH,Moorfields Eye NHS Foundation Trust,Antoni van Leeuwenhoek Hospital,UU,Yale University,UU,Millennium the Takeda Oncology Company,Bruker UK Ltd,ESI (United States),Microsoft Research,Teraview Ltd,University of Utah,Great Ormond Street Hospital Children's Charity,Creatv MicroTech (United States),Philips (Netherlands),Cancer Research UK,Alzheimer's Society,Pelican Cancer Foundation,Siemens AG,Lightpoint Medical Ltd,Siemens AG (International),Mediso,Siemens (United Kingdom),The Francis Crick Institute,Mirada Solutions,IXICO Ltd,Alzheimer's Society,University College Hospital,Pulseteq Ltd,Renishaw plc (UK),INRIA Sophia-Antipolis,Siemens (United States),University College London Hospitals,Moorfields Eye NHS Foundation Trust,Bruker (United Kingdom),Creatv MicroTech (United States),IXICO Technologies Ltd,Great Ormond Street Hospital Children's Charity,Microsoft Research,French Institute for Research in Computer Science and Automation,The Francis Crick Institute,MR Solutions Limited,Teraview Ltd,icoMetrix,Vision RT Ltd,Philips Healthcare (Global),Microsoft (United States),Millennium the Takeda Oncology Company,PerkinElmer (United Kingdom),Vision RT Ltd,Icometrix (Belgium),Blackford Analysis Ltd,IXICO Ltd,Pulseteq Ltd,RAPID Biomedical (Germany),Vision RT Ltd,Mediso,Bruker UK Ltd,Rigaku (United States),Rigaku,Hitachi Ltd,Hamamatsu Photonics (United Kingdom),Dexela Ltd,Fujifilm Visualsonics Inc,Imperial Cancer Research Fund,Precision Acoustics (United Kingdom),Agilent Technologies (United Kingdom),Danish Research Centre for Magnetic Reso,INRIA Sophia-Antipolis,Precision Acoustics (United Kingdom),MR Solutions Limited,WF,Dexela Ltd,Medtronic,GE Healthcare,Elekta (United Kingdom),Agency for Science, Technology and Research,Dexela Ltd,UCL,Hitachi (Japan),Danish Research Centre for Magnetic Reso,Philips Healthcare,Beijing Normal University,Creatv MicroTech (United States),PULSETEQ LIMITED,TeraView (United Kingdom),University of Pennsylvania,Huntington's Disease Association,Agilent Technologies (United Kingdom),Siemens AG,Child Health Research Appeal Trust,Olea Medical (France),Blackford Analysis Ltd,The Huntington's Disease Association,Medtronic (United States),WF,Yale University,Alzheimer's Society,Imaging Equipment Ltd,Child Health Research Appeal Trust,Beijing Normal University,RENISHAW,Netherlands Cancer Institute,Agency for Science Technology-A Star,Takeda (United States),Precision Acoustics (United Kingdom),Great Ormond Street Hospital for Children NHS Foundation Trust,ESI Group,GE Healthcare,Hamamatsu Photonics UK Ltd,Alzheimer’s Research UK,Alzheimer's Research UK,Wolfson Foundation,Samsung Advanced Institute of Technology,Fujifilm Visualsonics Inc,RENISHAW,Brain Products GmbH,Moorfields Eye Hospital NHS Foundation Trust,CANCER RESEARCH UK,Agilent Technologies (United Kingdom),Bruker UK Ltd,Imaging Equipment Limited,Renishaw (United Kingdom),Great Ormond Street Hospital,Child Health Research Appeal Trust,University College London Hospital (UCLH) NHS Foundation Trust,Teraview Ltd,ESI Group,Hamamatsu Photonics UK Ltd,University of Pennsylvania,Samsung (South Korea),Pelican Cancer Foundation,Olea Medical,The Francis Crick Institute,University College London Hospital (UCLH) NHS Foundation Trust,Mirada Solutions,RAPID Biomedical GmbH,Elekta UK LtdFunder: UK Research and Innovation Project Code: EP/L016478/1Funder Contribution: 5,782,530 GBPMedical imaging has transformed clinical medicine in the last 40 years. Diagnostic imaging provides the means to probe the structure and function of the human body without having to cut open the body to see disease or injury. Imaging is sensitive to changes associated with the early stages of cancer allowing detection of disease at a sufficient early stage to have a major impact on long-term survival. Combining imaging with therapy delivery and surgery enables 3D imaging to be used for guidance, i.e. minimising harm to surrounding tissue and increasing the likelihood of a successful outcome. The UK has consistently been at the forefront of many of these developments. Despite these advances we still do not know the most basic mechanisms and aetiology of many of the most disabling and dangerous diseases. Cancer survival remains stubbornly low for many of the most common cancers such as lung, head and neck, liver, pancreas. Some of the most distressing neurological disorders such as the dementias, multiple sclerosis, epilepsy and some of the more common brain cancers, still have woefully poor long term cure rates. Imaging is the primary means of diagnosis and for studying disease progression and response to treatment. To fully achieve its potential imaging needs to be coupled with computational modelling of biological function and its relationship to tissue structure at multiple scales. The advent of powerful computing has opened up exciting opportunities to better understand disease initiation and progression and to guide and assess the effectiveness of therapies. Meanwhile novel imaging methods, such as photoacoustics, and combinations of technologies such as simultaneous PET and MRI, have created entirely new ways of looking at healthy function and disturbances to normal function associated with early and late disease progression. It is becoming increasingly clear that a multi-parameter, multi-scale and multi-sensor approach combining advanced sensor design with advanced computational methods in image formation and biological systems modelling is the way forward. The EPSRC Centre for Doctoral Training in Medical Imaging will provide comprehensive and integrative doctoral training in imaging sciences and methods. The programme has a strong focus on new image acquisition technologies, novel data analysis methods and integration with computational modelling. This will be a 4-year PhD programme designed to prepare students for successful careers in academia, industry and the healthcare sector. It comprises an MRes year in which the student will gain core competencies in this rapidly developing field, plus the skills to innovate both with imaging devices and with computational methods. During the PhD (years 2 to 4) the student will undertake an in-depth study of an aspect of medical imaging and its application to healthcare and will seek innovative solutions to challenging problems. Most projects will be strongly multi-disciplinary with a principle supervisor being a computer scientist, physicist, mathematician or engineer, a second supervisor from a clinical or life science background, and an industrial supervisor when required. Each project will lie in the EPSRC's remit. The Centre will comprise 72 students at its peak after 4 years and will be obtaining dedicated space and facilities. The participating departments are strongly supportive of this initiative and will encourage new academic appointees to actively participate in its delivery. The Centre will fill a significant skills gap that has been identified and our graduates will have a major impact in academic research in his area, industrial developments including attracting inward investment and driving forward start-ups, and in advocacy of this important and expanding area of medical engineering.
All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://beta.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=ukri________::2b0503f80b56fc6c6a8b619775b1819c&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.eumore_vert All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://beta.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=ukri________::2b0503f80b56fc6c6a8b619775b1819c&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.euassignment_turned_in Project2019 - 2028Partners:UCL, Alzheimer's Society, Precision Acoustics (United Kingdom), Max-Planck-Gymnasium, Fujifilm Visualsonics Inc +110 partnersUCL,Alzheimer's Society,Precision Acoustics (United Kingdom),Max-Planck-Gymnasium,Fujifilm Visualsonics Inc,Mediso,Siemens (United Kingdom),Shimadzu (Japan),National Physical Laboratory,IXICO Technologies Ltd,MR Solutions Limited,Motor Neurone Disease Association,SU,Indigo Scientific Ltd,Stanford University,Visulytix Ltd,General Electric (United Kingdom),Brain Products GmbH,Nikon Metrology UK Ltd,Rigaku,Intuitive Surgical Inc,Moorfields Eye NHS Foundation Trust,COSMONiO Ltd,Perceive3D,MS,GE Healthcare,Rosalind Franklin Institute,GlaxoSmithKline (United Kingdom),Philips Healthcare (Global),Vision RT Ltd,Bruker UK Ltd,Research Complex at Harwell,GE Healthcare,Alzheimer’s Research UK,Moorfields Eye Hospital NHS Foundation Trust,Biogen,Alzheimer's Society,Motor Neurone Disease Association,Visulytix Ltd,Stanford University Medical School,Mediso,Scintacor Ltd,Eli Lilly and Company Limited,Digital Surgery,Direct Conversion GmbH,SmartTarget Ltd,Gold Standard Phantoms,The Rosalind Franklin Institute,Creatv MicroTech (United States),Mirada Medical (United Kingdom),IXICO Ltd,IXICO Ltd,SIEMENS PLC,UCL Hospitals NHS Foundation Trust,Indigo Scientific Ltd,Great Ormond Street Hospital Children's Charity,Moorfields Eye NHS Foundation Trust,Creatv MicroTech (United States),QMENTA Imaging SL,Fujifilm Visualsonics Inc,Mirada Medical UK,Precision Acoustics (United Kingdom),Precision Acoustics (United Kingdom),MR Solutions Limited,Max-Planck-Gymnasium,Perceive3D,Philips Healthcare,Creatv MicroTech (United States),SmartTarget Ltd,NPL,NPL,QMENTA Imaging SL,Bruker UK Ltd,Great Ormond Street Hospital Children's Charity,Intuitive Surgical Inc,GlaxoSmithKline PLC,Digital Surgery,Siemens PLC,icoMetrix,Vision RT Ltd,Vision RT Ltd,Icometrix (Belgium),Scintacor Ltd,Cystic Fibrosis Trust,Eli Lilly (United Kingdom),COSMONiO Ltd,MS,Bruker (United Kingdom),Nikon Metrology UK Ltd,Rigaku (United States),SIEMENS PLC,Elekta (United Kingdom),Eli Lilly and Company Limited,Multiple Sclerosis Society,Great Ormond Street Hospital for Children NHS Foundation Trust,Alzheimer's Research UK,Brain Products GmbH,Bruker UK Ltd,Shimadzu Corp.,Great Ormond Street Hospital,University College London Hospital (UCLH) NHS Foundation Trust,GSK,Nikon (United Kingdom),CYSTIC FIBROSIS TRUST,Cystic Fibrosis Trust,Direct Conversion GmbH,Philips (Netherlands),Alzheimer's Society,Gold Standard Phantoms,Max Planck Institutes,Shimadzu Corp.,University College London Hospital (UCLH) NHS Foundation Trust,RCaH,Elekta UK Ltd,BiogenFunder: UK Research and Innovation Project Code: EP/S021930/1Funder Contribution: 6,034,270 GBPWe propose to create the EPSRC Centre for Doctoral Training (CDT) in intelligent integrated imaging in healthcare (i4health) at University College London (UCL). Our aim is to nurture the UK's future leaders in next-generation medical imaging research, development and enterprise, equipping them to produce future disruptive healthcare innovations either focused on or including imaging. Building on the success of our current CDT in Medical Imaging, the new CDT will focus on an exciting new vision: to unlock the full potential of medical imaging by harnessing new associated transformative technologies enabling us to consider medical imaging as a component within integrated healthcare systems. We retain a focus on medical imaging technology - from basic imaging technologies (devices and hardware, imaging physics, acquisition and reconstruction), through image computing (image analysis and computational modeling), to integrated image-based systems (diagnostic and interventional systems) - topics we have developed world-leading capability and expertise on over the last decade. Beyond this, the new initiative in i4health is to capitalise on UCL's unique combination of strengths in four complementary areas: 1) machine learning and AI; 2) data science and health informatics; 3) robotics and sensing; 4) human-computer interaction (HCI). Furthermore, we frame this research training and development in a range of clinical areas including areas in which UCL is internationally leading, as well as areas where we have up-and-coming capability that the i4health CDT can help bring to fruition: cancer imaging, cardiovascular imaging, imaging infection and inflammation, neuroimaging, ophthalmology imaging, pediatric and perinatal imaging. This unique combination of engineering and clinical skills and context will provide trainees with the essential capabilities for realizing future image-based technologies. That will rely on joint modelling of imaging and non-imaging data to integrate diverse sources of information, understanding of hardware the produces or uses images, consideration of user interaction with image-based information, and a deep understanding of clinical and biomedical aims and requirements, as well as an ability to consider research and development from the perspective of responsible innovation. Building on our proven track record, we will attract the very best aspiring young minds, equipping them with essential training in imaging and computational sciences as well as clinical context and entrepreneurship. We will provide a world-class research environment and mentorship producing a critical mass of future scientists and engineers poised to develop and translate cutting-edge engineering solutions to the most pressing healthcare challenges.
All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://beta.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=ukri________::3d6c1ad67933256e267346d145bf8ee3&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.eumore_vert All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://beta.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=ukri________::3d6c1ad67933256e267346d145bf8ee3&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.eu